Avicanna

Canada is buzzing after the legalization of recreational cannabis, with long lines at the few retailers already open, a supply shortage, impaired driving fears, people taking to the streets in joy ...  But what does legalization mean for the Canadian economy? How much is the market...

Key players in the cannabis industry shared their views on emerging market opportunities in the sector at the Benzinga Cannabis Capital Conference in Toronto. Common themes among the execs were the importance of finding good partners, focusing on diversity and expanding brands. Supreme Cannabis...

By Etan Vlessing Pure Global Cannabis (OTC: PRCNF) has launched an aggressive growth strategy beyond Canada to establish itself as a international force in the cannabis business, Stephen Pynn, the company's vice president of corporate development, said Friday at the Benzinga Cannabis...

A few months ago, Benzinga visited several countries in South America and subsequently published an article explaining why cannabis investors’ interest in the region, especially in Colombia, was about to spike. In the weeks that followed, numerous U.S. and Canada-based marijuana companies...

Cannabis investors can't afford to miss the Benzinga Cannabis Capital Conference, a premier gathering of investors and entrepreneurs painting an honest picture of the opportunities and challenges in cannabis investing. Space is limited—get your tickets before they sell out. Ahead of the...

Almost every week, an American or Canadian cannabis company announces a large overseas investment. And it's no longer just Germany, Israel and Australia that are piquing investors’ interest. Emerging markets like Jamaica are also turning heads. The largest investment opportunities might...

Shares of GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) were halted Thursday, ahead of a Food and Drug Administration vote on the company's cannabis-derived drug Epidiolex. Trading resumed after the FDA advisory panel voted unanimously in favor of approving the medicine for the treatment of two...

April started with considerable pressure on the markets. “Concerns over legalization in Canada, previously assumed to be a ‘done deal,’ continue to weigh on investors, along with fears of a supply glut, as discussed on the cover of Barron’s this week,” 420 Investor...

While reporting for a book on the cannabis business I recently finished writing, I realized many people don't differentiate smoking weed from using cannabis. “Isn’t it the same?” is the question I was asked far too often. The answer: certainly not. Smoking is just one of many...

Medical journal The Lancet published an article Wednesday that could mold the future of cannabis-derived therapeutics. The piece in question featured results from GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) and Greenwich Biosciences’ Phase 3 study of Epidiolex — an oral cannabidiol...